Atacicept in multiple sclerosis (ATAMS): a randomised, placebo-controlled, double-blind, phase 2 trial.

Kappos L, Hartung H-P, Freedman MS, Boyko A, Radü E W, Mikol DD, Lamarine M, Hyvert Y, Freudensprung U, Plitz T, et al.